Region-specific Alterations of A-to-I RNA Editing of Serotonin 2c Receptor in the Cortex of Suicides with Major Depression
Overview
Public Health
Authors
Affiliations
Brain region-specific abnormalities in serotonergic transmission appear to underlie suicidal behavior. Alterations of RNA editing on the serotonin receptor 2C (HTR2C) pre-mRNA in the brain of suicides produce transcripts that attenuate 5-HT2CR signaling by impairing intracellular G-protein coupling and subsequent intracellular signal transduction. In brain, the distribution of RNA-editing enzymes catalyzing deamination (A-to-I modification) shows regional variation, including within the cerebral cortex. We tested the hypothesis that altered pre-mRNA 5-HT2CR receptor editing in suicide is region-specific. To this end, we investigated the complete 5-HT2CR mRNA-editing profile in two architectonically distinct cortical areas involved in mood regulation and decision-making in a clinically well-characterized cohort of age- and sex-matched non-psychiatric drug-free controls and depressed suicides. By using an original biochemical detection method, that is, capillary electrophoresis single-stranded conformational polymorphism (CE-SSCP), we corroborated the 5-HT2CR mRNA-editing profile previously described in the dorsolateral prefrontal cortex (Brodmann area 9 (BA9)). Editing of 5-HT2CR mRNA displayed clear regional difference when comparing dorsolateral prefrontal cortex (BA9) and anterior cingulate cortex (BA24). Compared with non-psychiatric control individuals, alterations of editing levels of 5-HT2CR mRNA were detected in both cortical areas of depressed suicides. A marked increase in editing on 5-HT2CR was especially observed in the anterior cingulate cortex in suicides, implicating this cortical area in suicide risk. The results suggest that region-specific changes in RNA editing of 5-HT2CR mRNA and deficient receptor function likely contribute to the etiology of major depressive disorder or suicide.
Miranda-Mendizabal A, Vetter D, Zambrano J, Zarp J, Chavarria V, Gimenez-Palomo A Ann Gen Psychiatry. 2025; 24(1):7.
PMID: 39915772 PMC: 11803998. DOI: 10.1186/s12991-024-00544-8.
Checa-Robles F, Salvetat N, Cayzac C, Menhem M, Favier M, Vetter D Int J Mol Sci. 2024; 25(23).
PMID: 39684694 PMC: 11641080. DOI: 10.3390/ijms252312981.
Genetics of cell-type-specific post-transcriptional gene regulation during human neurogenesis.
Aygun N, Vuong C, Krupa O, Mory J, Le B, Valone J Am J Hum Genet. 2024; 111(9):1877-1898.
PMID: 39168119 PMC: 11393701. DOI: 10.1016/j.ajhg.2024.07.015.
Mercer H, Nair A, Ridgel A, Piontkivska H PLoS One. 2023; 18(12):e0287078.
PMID: 38134032 PMC: 10745226. DOI: 10.1371/journal.pone.0287078.
Advances in brain epitranscriptomics research and translational opportunities.
Zhang F, Ignatova V, Ming G, Song H Mol Psychiatry. 2023; 29(2):449-463.
PMID: 38123727 PMC: 11116067. DOI: 10.1038/s41380-023-02339-x.